Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence.

Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring Implications.

Erectile impotence in diabetic men: aetiology, investigation, and management.

Testosterone replacement therapy and sleep-related erections in hypogonadal men.

Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men.

Safety of testosterone enanthate.

Letter: Erectile impotence.

Penile blood pressure in the evaluation of erectile impotence.

Risks of testosterone therapy in elderly men.

Combined testosterone and vardenafil treatment for restoring erectile function in hypogonadal patients who failed to respond to testosterone therapy alone.

Letter: Erectile impotence.

Editorial: Treatment of erectile impotence.

Penile prostheses in erectile impotence.

Serum-testosterone during oral administration of testosterone in hypogonadal men and transsexual women.

Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate.

Effect of a single injection of testosterone enanthate on 17β estradiol and bone turnover markers in hypogonadal male patients.

A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men.

Hypogonadal symptoms are associated with different serum testosterone thresholds in middle-aged and elderly men.

Pharmacocavernometry in the assessment of erectile impotence.

Changes in sperm morphology in normal men treated with danazol and testosterone.

Impotence in elderly men.

Neurological risk profile in organic erectile impotence.

The role of yohimbine for the treatment of erectile impotence.

Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men.

Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.

Suggest Documents

Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring Implications.

Erectile impotence in diabetic men: aetiology, investigation, and management.

Testosterone replacement therapy and sleep-related erections in hypogonadal men.

Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men.

Safety of testosterone enanthate.

Letter: Erectile impotence.

Penile blood pressure in the evaluation of erectile impotence.

Risks of testosterone therapy in elderly men.

Combined testosterone and vardenafil treatment for restoring erectile function in hypogonadal patients who failed to respond to testosterone therapy alone.

Letter: Erectile impotence.

Editorial: Treatment of erectile impotence.

Penile prostheses in erectile impotence.

Serum-testosterone during oral administration of testosterone in hypogonadal men and transsexual women.

Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate.

Effect of a single injection of testosterone enanthate on 17β estradiol and bone turnover markers in hypogonadal male patients.

A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men.

Hypogonadal symptoms are associated with different serum testosterone thresholds in middle-aged and elderly men.

Pharmacocavernometry in the assessment of erectile impotence.

Changes in sperm morphology in normal men treated with danazol and testosterone.

Impotence in elderly men.

Neurological risk profile in organic erectile impotence.

The role of yohimbine for the treatment of erectile impotence.

Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men.

Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.

Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence.

Recommend Documents

Follow Us